Abstract

BackgroundOrganophosphate esters (OPEs)—used as flame retardants and plasticizers—are associated with adverse pregnancy outcomes such as reduced fecundity and live births and increased preterm delivery. OPEs may interfere with growth and metabolism via endocrine-disruption, but few studies have investigated endocrine-related outcomes. The objective of this pilot study (n = 56 mother-infant pairs) was to evaluate associations of OPEs with gestational weight gain (GWG), gestational age at delivery, infant anthropometry, and infant feeding behaviors.MethodsWe quantified OPE metabolites (bis-2-chloroethyl phosphate [BCEP], bis (1,3-dichloro-2-propyl) phosphate [BDCPP], diphenyl phosphate [DPHP]) in pooled maternal spot urine collected throughout pregnancy (~ 12, 28, and 35 weeks’ gestation). We obtained maternal sociodemographic characteristics from questionnaires administered at enrollment and perinatal characteristics from medical record abstraction. Trained research assistants measured infant weight, length, head and abdominal circumferences, and skinfold thicknesses at birth and 6 weeks postpartum. Mothers reported infant feeding behavior via the Baby Eating Behavior Questionnaire (BEBQ). Using multiple linear regression, we assessed associations of log2-transformed maternal urinary OPE metabolites with GWG, gestational age at delivery, infant anthropometry at birth, weekly growth rate, and BEBQ scores at 6 weeks postpartum. We used linear mixed effects (LME) models to analyze overall infant anthropometry during the first 6 weeks of life. Additionally, we considered effect modification by infant sex.ResultsWe observed weak positive associations between all OPE metabolites and GWG. In LME models, BDCPP was associated with increased infant length (β = 0.44 cm, 95%CI = 0.01, 0.87) and weight in males (β = 0.14 kg, 95%CI = 0.03, 0.24). BDCPP was also associated with increased food responsiveness (β = 0.23, 95%CI = 0.06, 0.40). DPHP was inversely associated with infant abdominal circumference (β = − 0.50 cm, 95%CI = − 0.86, − 0.14) and female weight (β = − 0.19 kg, 95%CI = − 0.36, − 0.02), but positively associated with weekly growth in iliac skinfold thickness (β = 0.10 mm/wk., 95%CI = 0.02, 0.19). Further, DPHP was weakly associated with increased feeding speed. BCEP was associated with greater infant thigh skinfold thickness (β = 0.34 mm, 95%CI = 0.16, 0.52) and subscapular skinfold thickness in males (β = 0.14 mm, 95%CI = 0.002, 0.28).ConclusionsCollectively, these findings suggest that select OPEs may affect infant anthropometry and feeding behavior, with the most compelling evidence for BDCPP and DPHP.

Highlights

  • The use of organophosphate esters (OPEs) as flame retardants in consumer products such as residential and office furniture, baby products, and electronics has increased since polybrominated diphenyl ethers (PBDEs) were phased-out of use and production between 2004 and 2013 in the USA [1] amid growing concerns about their toxicity [2,3,4,5]

  • Collectively, these findings suggest that select Organophosphate ester (OPE) may affect infant anthropometry and feeding behavior, with the most compelling evidence for BDCPP and diphenyl phosphate (DPHP)

  • Considering prior research, which suggests that OPEs may alter metabolic homeostasis and induce weight gain, we evaluated the hypotheses that OPE exposure during pregnancy affects: gestational weight gain (GWG) among pregnant women, infant gestational age at delivery, infant anthropometric measures of size and body composition at birth and growth during the first 6 weeks of life, and infant feeding behavior in a pregnancy cohort

Read more

Summary

Introduction

The use of organophosphate esters (OPEs) as flame retardants in consumer products such as residential and office furniture, baby products, and electronics has increased since polybrominated diphenyl ethers (PBDEs) were phased-out of use and production between 2004 and 2013 in the USA [1] amid growing concerns about their toxicity [2,3,4,5]. Experimental studies suggest that OPEs are endocrinedisrupting compounds that may interfere with growth and metabolism. In vitro and in vivo toxicological studies provide evidence that OPEs have the capacity to disrupt growth and metabolism through endocrine-related mechanisms of action. Organophosphate esters (OPEs)—used as flame retardants and plasticizers—are associated with adverse pregnancy outcomes such as reduced fecundity and live births and increased preterm delivery. OPEs may interfere with growth and metabolism via endocrine-disruption, but few studies have investigated endocrinerelated outcomes. The objective of this pilot study (n = 56 mother-infant pairs) was to evaluate associations of OPEs with gestational weight gain (GWG), gestational age at delivery, infant anthropometry, and infant feeding behaviors

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call